<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02530073</url>
  </required_header>
  <id_info>
    <org_study_id>15-0874</org_study_id>
    <nct_id>NCT02530073</nct_id>
  </id_info>
  <brief_title>Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO)</brief_title>
  <acronym>FETO</acronym>
  <official_title>Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The rationale for fetal therapy in severe congenital diaphragmatic hernia (CDH) is to restore
      adequate lung growth for neonatal survival.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prenatal tracheal occlusion (TO) obstructs the normal egress of lung fluid during pulmonary
      development leading to increased lung tissue stretch, increased cell proliferation, and
      accelerated lung growth. European colleagues have developed foregut endoscopy and techniques
      to position and remove endoluminal tracheal balloons in utero. Recently, the Belgium group
      published summary results of FETO showing an improved survival in 175 patients with isolated
      left CDH from 24% to 49%.

      The goal of this pilot study is to study the feasibility of implementing FETO therapy in the
      most severe group of fetuses with left CDH Observed/expected lung-to-head ratio &lt; 25%(O/E LHR
      &lt; 25%).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">February 2023</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent of neonatal survivors at time of discharge</measure>
    <time_frame>Discharge from the hospital, an expected average of 12 weeks.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prenatal increase in lung volume</measure>
    <time_frame>2 weeks (prenatally)</time_frame>
    <description>Lung volume after FETO procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days of Postnatal mechanical ventilator support</measure>
    <time_frame>First 28 days of postnatal life</time_frame>
    <description>mechanical ventilator support will be monitored and recorded in days of use</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Congenital Diaphragmatic Hernias</condition>
  <arm_group>
    <arm_group_label>Fetoscopic Endoluminal Tracheal Occlusion (FETO)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An un-blinded non-randomized single arm pilot study of FETO in fetuses with congenital diaphragmatic hernia (CDH)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fetoscopic Endoluminal Tracheal Occlusion (FETO)</intervention_name>
    <description>This study will position and remove an endoluminal tracheal balloon in utero (FETO) to study the feasibility of implementing FETO therapy in the most severe group of fetuses with left CDH (O/E LHR &lt; 25%).</description>
    <arm_group_label>Fetoscopic Endoluminal Tracheal Occlusion (FETO)</arm_group_label>
    <other_name>BALT GOLDBAL2 Tracheal Balloon Catheter system</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women age 18 years and older, who are able to consent

          -  Singleton pregnancy

        Fetal

          -  Normal Karyotype

          -  Fetal Diagnosis of Isolated Left CDH with liver up

          -  Gestation at enrollment prior to 29 wks plus 6 days

          -  SEVERE pulmonary hypoplasia with Uultra Sound O/E LHR &lt; 25%

        Exclusion Criteria:

          -  Pregnant women &lt;18 years of age.

          -  Maternal contraindication to fetoscopic surgery or severe maternal medical condition
             in pregnancy

          -  Technical limitations precluding fetoscopic surgery

          -  Rubber latex allergy

          -  Preterm labor, cervix shortened (&lt;15 mm at enrollment or within 24 hours of FETO
             balloon insertion procedure) or uterine anomaly strongly predisposing to preterm
             labor, placenta previa

          -  Psychosocial ineligibility, precluding consent

          -  Diaphragmatic hernia: right-sided or bilateral, major associated anomalies, isolated
             left-sided with the O/E LHR â‰¥ 25%

          -  Inability to remain at FETO site during time period of tracheal occlusion, delivery
             and postnatal care
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy Crombleholme, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeannie Zuk, PhD</last_name>
    <phone>720.777.6690</phone>
    <email>Jeannie.Zuk@childrenscolorado.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Childrens Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeannie Zuk, PhD</last_name>
      <phone>720-777-6690</phone>
      <email>Jeannie.zuk@childrenscolorado.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 31, 2015</study_first_submitted>
  <study_first_submitted_qc>August 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2015</study_first_posted>
  <last_update_submitted>September 1, 2017</last_update_submitted>
  <last_update_submitted_qc>September 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>congenital diaphragmatic hernia</keyword>
  <keyword>FETO</keyword>
  <keyword>tracheal occlusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Diaphragmatic</mesh_term>
    <mesh_term>Hernias, Diaphragmatic, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

